ArticleEmerging infectious diseases2004
Economics and preventing hospital-acquired infection.
Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Point prevalence surveys of health-care-associated infections: a systematic review.Pathogens and global health · 2019Pooled it
- Cost-effectiveness of an Environmental Cleaning Bundle for Reducing Healthcare-associated Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Trial
- Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial.Implementation science : IS · 2016Trial
- Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial.Infection control and hospital epidemiology · 2014Trial
- Deployment of real-time particle detection monitoring system in operating theatres for airborne contamination assessments : a methodological evaluation.Bone & joint open · 2025Article
- Measuring the burden of nosocomial infection in cancer patients: an analysis based on propensity score matching in China.Frontiers in public health · 2025Article
- Topical Drug Delivery in the Treatment of Skin Wounds and Ocular Trauma Using the Platform Wound Device.Pharmaceutics · 2023Review
- Evaluation of Patients' Adverse Events During Contact Isolation for Vancomycin-Resistant Enterococci Using a Matched Cohort Study With Propensity Score.JAMA network open · 2022Article
- Article
- Observational
- How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling Study.American journal of epidemiology · 2021Article
- The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States.The Journal of infectious diseases · 2020Article
- Development and pilot of a multicriteria decision analysis (MCDA) tool for health services administrators.BMJ open · 2019Article
- ROS mediated antibacterial activity of photoilluminated riboflavin: A photodynamic mechanism against nosocomial infections.Toxicology reports · 2019Article
- Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Article
- Economic evaluation of interventions designed to reduce Clostridium difficile infection.PloS one · 2018Article
- Effects of operational decisions on the diffusion of epidemic disease: A system dynamics modeling of the MERS-CoV outbreak in South Korea.Journal of theoretical biology · 2017Article
- Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2017Article
- The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2016Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The economics of preventing hospital-acquired infections is most often described in general terms. The underlying concepts and mechanisms are rarely made explicit but should be understood for research and policy-making. We define the key economic concepts and specify an illustrative model that uses hypothetical data to identify how two related questions might be addressed: 1) how much should be invested for infection control, and 2) what are the most appropriate infection-control programs? We aim to make explicit the economics of preventing hospital-acquired infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.